A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Clinical trial NCT07176390 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07176390
Sponsor: Merck Sharp & Dohme LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2025-10-08
Primary completion: 2026-09-05
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.